Clinipace ranked 279th in the prestigious list of fastest-growing American companies

MORRISVILLE, N.C. (Business Wire) August 23, 2011 – Clinipace Worldwide, a global digital clinical research organization (dCRO), has announced that the company has been named to Inc. Magazine’s 30th annual Inc. 500/5000. This prestigious list is a compilation of the fastest-growing privately held companies in the country, recognizing their success and potential for the future.

Ranked 279 overall and 20th among Inc’s list of Top Heath Companies as a result of 1,170% growth over the past three-year period, Clinipace Worldwide joins the rarified company of organizations that have appeared on the list multiple times. Last year, Clinipace ranked 485th overall.

Clinipace Worldwide is dedicated to providing fully-integrated technology-amplified clinical research solutions and services. The company’s strategic mix of global therapeutic and regulatory experience, drug and device development expertise and clinical operations capabilities has enabled them to achieve such impressive growth over the past several years. With specific expertise in managing oncology trials, Clinipace has managed over 500 global contract research and regulatory projects.

“We’re honored to have been named to the Inc. 500 list two years in a row, which is not often achieved. We attribute this accomplishment to the dedication and innovation of our employees in serving clients,” said Jeff Williams, Chairman and CEO, Clinipace Worldwide. “As we look forward to the next three years, we plan to continue building our global capacity and delivering innovative contract research services and technology to support growth.”

This year’s winners will be honored at the 30th Annual Inc. 500|5000 Conference and Awards Ceremony September 22-24, 2011 at the Gaylord National Resort and Conference Center in Washington D.C.

About Inc. 500|5000 List

In 1982, Inc. introduced the Inc. 500 list of the fastest-growing privately held companies in the United States. Since then, this prestigious list of the nation’s most successful private companies has become the hallmark of entrepreneurial success and the place where future household names first make their mark. Oracle, Patagonia, E*Trade, American Apparel, Zipcar and numerous other well-known brands have been honored by the Inc. 500|5000. In 2007, the Inc. 500 list expanded to the Inc. 500|5000, giving readers a deeper, richer understanding of the entrepreneurial landscape and capturing a broader spectrum of success.

Today, the list is a distinguished editorial award, a celebration of innovation, a network of entrepreneurial leaders, and an effective public relations showcase. The Inc. 500|5000 ranks companies by overall revenue growth over a three-year period. All 5,000 honoree companies are individually profiled on The top 500 are featured in the September issue of Inc. magazine, the leading entrepreneurial advocate for 30 years running. Inc. also ranks the fastest-growing companies by industry, metro area, revenue, and number of employees, and we also highlight women- and minority- run companies.

About Clinipace Worldwide

Clinipace Worldwide, a global digital clinical research organization (dCRO), specializes in fully-integrated clinical research services for biopharmaceutical and medical device firms. Optimized by TEMPO™, its proprietary eClinical platform, the Clinipace team of experts brings extensive knowledge and insight into site selection, patient recruitment, clinical operations, data management, medical monitoring, biostatistics, and regulatory affairs to ensure a successful clinical development program through proactve clinical trial management. With specific expertise in oncology, among other therapeutic areas, Clinipace Worldwide has managed over 500 global contract research and regulatory projects. Clinipace Worldwide is headquartered in Research Triangle Park, North Carolina with offices in Overland Park, Kansas, Boulder, Colorado, Zurich, Switzerland, Munich, Germany, Tel-Aviv, Israel, New Delhi, India, Sao Paulo, Brazil, Buenos Aires, Argentina, and Lima, Peru. For more information visit our website at